• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用免疫磁珠阳性分选系统分离人CD34+外周血干细胞:预先使用尼龙毛柱去除单核细胞。

Isolation of human CD34+ peripheral blood stem cells using an immunomagnetic positive selection system: prior monocyte depletion using a nylon-wool column.

作者信息

Nakamura Y, Noma M, Kidokoro M, Kobayashi N, Takei M, Kurashima S, Mukaiyama T, Kato S

机构信息

Blood Transfusion Center, Tokai University Hospital, Kanagawa, Japan.

出版信息

J Hematother. 1994 Summer;3(2):128-33.

PMID:7522896
Abstract

An immunomagnetic separation system has been used to collect CD34+ cells in mobilized blood after treatment with a nylon-wool column. Cell purities were increased from 2.6% preseparation to 94.6% postseparation, with a mean yield 45.2% (n = 4). Forty percent of CD34+ cells separated by the immunomagnetic procedure formed colonies in the presence of hematopoietic growth factors in a limiting dilution assay. Eleven percent of these clones proliferated to over 10(5) cells and contained megakaryocytes.

摘要

一种免疫磁珠分离系统已被用于在尼龙棉柱处理后收集动员血液中的CD34+细胞。细胞纯度从分离前的2.6%提高到分离后的94.6%,平均回收率为45.2%(n = 4)。在有限稀释分析中,通过免疫磁珠程序分离的CD34+细胞中有40%在造血生长因子存在的情况下形成集落。这些克隆中有11%增殖到超过10(5)个细胞,并含有巨核细胞。

相似文献

1
Isolation of human CD34+ peripheral blood stem cells using an immunomagnetic positive selection system: prior monocyte depletion using a nylon-wool column.使用免疫磁珠阳性分选系统分离人CD34+外周血干细胞:预先使用尼龙毛柱去除单核细胞。
J Hematother. 1994 Summer;3(2):128-33.
2
A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.一种涂有人免疫球蛋白的尼龙羊毛过滤器,用于从外周血干细胞移植中快速去除单核细胞和髓细胞。
Exp Hematol. 1998 May;26(5):400-8.
3
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.在高剂量治疗后用于造血挽救的外周血祖细胞样本中,同时进行免疫磁珠法CD34+细胞分选和乳腺癌细胞清除的有效性和安全性。
Clin Cancer Res. 1999 May;5(5):1035-40.
4
Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods.利用免疫磁选法从异基因外周血祖细胞(PBPC)中进行阳性和阴性细胞的联合分选。
Bone Marrow Transplant. 2001 Apr;27(7):683-7. doi: 10.1038/sj.bmt.1702860.
5
Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.通过美天旎CD34+细胞分选系统从血液移植中清除bcl-2-IgH阳性滤泡性淋巴瘤细胞,同时高效恢复造血祖细胞。
Bone Marrow Transplant. 1996 Dec;18(6):1117-21.
6
Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.从人骨髓、外周血和脐带血中获取、鉴定及培养CD34+细胞。
Blood Cells. 1994;20(2-3):411-23.
7
A rapid nylon-fiber syringe system to deplete CD14+ cells for positive selection of human blood CD34+ cells. Use of immunomagnetic microspheres.一种用于耗尽CD14+细胞以阳性选择人血CD34+细胞的快速尼龙纤维注射器系统。免疫磁微球的应用。
Bone Marrow Transplant. 1997 Feb;19(4):373-9. doi: 10.1038/sj.bmt.1700659.
8
Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells.通过结合CD34阳性造血干细胞的免疫磁珠阳性选择和肿瘤细胞的阴性选择(清除)来改善肿瘤细胞清除。
Bone Marrow Transplant. 1999 Apr;23(8):809-17. doi: 10.1038/sj.bmt.1701656.
9
Immunomagnetic positive selection and colony culture of CD34+ cells from blood.血液中CD34+细胞的免疫磁珠阳性分选及集落培养
J Hematother. 1993 Summer;2(2):247-50. doi: 10.1089/scd.1.1993.2.247.
10
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.巨核细胞祖细胞的体外扩增:多种生长因子组合对来自骨髓和粒细胞集落刺激因子动员的外周血的CD34+祖细胞的影响。
Exp Hematol. 1997 Oct;25(11):1125-39.